NO175882C - Fremgangsmåte ved fremstilling av parenterale, antiparasittiske formuleringer av forbindelsen 25-cykloheksyl-avermectin B1 - Google Patents

Fremgangsmåte ved fremstilling av parenterale, antiparasittiske formuleringer av forbindelsen 25-cykloheksyl-avermectin B1

Info

Publication number
NO175882C
NO175882C NO901637A NO901637A NO175882C NO 175882 C NO175882 C NO 175882C NO 901637 A NO901637 A NO 901637A NO 901637 A NO901637 A NO 901637A NO 175882 C NO175882 C NO 175882C
Authority
NO
Norway
Prior art keywords
parenteral
compound
preparation
cyclohexyl avermectin
antiparasitic formulations
Prior art date
Application number
NO901637A
Other languages
English (en)
Norwegian (no)
Other versions
NO901637L (no
NO175882B (no
NO901637D0 (no
Inventor
Stephen Richard Wicks
Edward Davison
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898908071A external-priority patent/GB8908071D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of NO901637D0 publication Critical patent/NO901637D0/no
Publication of NO901637L publication Critical patent/NO901637L/no
Publication of NO175882B publication Critical patent/NO175882B/no
Publication of NO175882C publication Critical patent/NO175882C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
NO901637A 1989-04-11 1990-04-10 Fremgangsmåte ved fremstilling av parenterale, antiparasittiske formuleringer av forbindelsen 25-cykloheksyl-avermectin B1 NO175882C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898908071A GB8908071D0 (en) 1989-04-11 1989-04-11 Antiparasitic formulations
SG27894A SG27894G (en) 1989-04-11 1994-02-22 Injectable compositions containing 25-cyclohexyl-avermectin B1

Publications (4)

Publication Number Publication Date
NO901637D0 NO901637D0 (no) 1990-04-10
NO901637L NO901637L (no) 1990-10-12
NO175882B NO175882B (no) 1994-09-19
NO175882C true NO175882C (no) 1994-12-28

Family

ID=26295191

Family Applications (1)

Application Number Title Priority Date Filing Date
NO901637A NO175882C (no) 1989-04-11 1990-04-10 Fremgangsmåte ved fremstilling av parenterale, antiparasittiske formuleringer av forbindelsen 25-cykloheksyl-avermectin B1

Country Status (16)

Country Link
EP (1) EP0393890B1 (enExample)
JP (1) JPH0647548B2 (enExample)
CN (1) CN1035356C (enExample)
AP (1) AP133A (enExample)
AU (1) AU609660B2 (enExample)
CY (1) CY1777A (enExample)
DK (1) DK0393890T3 (enExample)
EG (1) EG18956A (enExample)
ES (1) ES2052173T3 (enExample)
FI (1) FI92015C (enExample)
GR (1) GR3005794T3 (enExample)
HK (1) HK39294A (enExample)
NO (1) NO175882C (enExample)
OA (1) OA09203A (enExample)
RU (1) RU1836084C (enExample)
SG (1) SG27894G (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19613972A1 (de) * 1996-04-09 1997-10-16 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen auf Basis von Rizinusöl
EP0928136B1 (en) * 1996-06-05 2003-10-22 Ashmont Holdings Limited Injectable compositions
DE19638045A1 (de) * 1996-09-18 1998-03-19 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen
KR20000025762A (ko) * 1998-10-14 2000-05-06 유충식 이버멕틴류의 가용화 조성물
GB9827727D0 (en) 1998-12-16 1999-02-10 Pfizer Ltd Antiparasitic formulations
US20100022469A1 (en) * 2008-06-24 2010-01-28 Majid Razzak Anthelminthic formulations
PL2396006T3 (pl) * 2009-02-16 2013-06-28 Zoetis Llc Preparat zawierający doramektynę w dużej dawce
MX2012004133A (es) * 2009-10-07 2012-05-08 Wyeth Llc Composiciones que comprenden adyuvante, macrolido y antigeno proteico y procedimientos de uso de las mismas.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8704545A1 (es) * 1984-09-14 1987-04-01 Glaxo Group Ltd Un procedimiento para preparar un nuevo antibiotico por fer-mentacion
IL78621A (en) * 1985-04-30 1991-06-30 American Cyanamid Co Mylbemycin analogs,their preparation and pesticidal compositions containing them
US4707470A (en) * 1985-05-17 1987-11-17 Smithkline Beckman Corporation Polyene antibiotic emulsion formulation
EP0285561A3 (de) * 1987-03-27 1989-10-25 Ciba-Geigy Ag Parasitizide und insektizide Milbemycin-Derivate
PT88952B (pt) * 1987-11-09 1993-02-26 Pfizer Processo para a preparacao de avermectinas etiladas

Also Published As

Publication number Publication date
EP0393890B1 (en) 1992-08-12
CY1777A (en) 1995-10-20
AP133A (en) 1991-06-05
SG27894G (en) 1995-03-17
GR3005794T3 (enExample) 1993-06-07
FI92015C (fi) 1994-09-26
CN1035356C (zh) 1997-07-09
AP9000174A0 (en) 1990-04-30
OA09203A (fr) 1992-06-30
EG18956A (en) 1994-04-30
FI901816A0 (fi) 1990-04-10
RU1836084C (ru) 1993-08-23
FI92015B (fi) 1994-06-15
JPH0647548B2 (ja) 1994-06-22
CN1046282A (zh) 1990-10-24
HK39294A (en) 1994-05-06
EP0393890A1 (en) 1990-10-24
DK0393890T3 (da) 1992-09-28
AU609660B2 (en) 1991-05-02
NO901637L (no) 1990-10-12
ES2052173T3 (es) 1994-07-01
NO175882B (no) 1994-09-19
JPH02290820A (ja) 1990-11-30
AU5311990A (en) 1990-11-08
NO901637D0 (no) 1990-04-10

Similar Documents

Publication Publication Date Title
NO179518C (no) AnalogifremgangsmÕte for fremstilling av 2- hydroksymetylcytosin-substituerte 1,3-oksatiolaner
MA22923A1 (fr) Procede de preparation de nouveaux composes .
NO179639C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte piperidinforbindelser
NO885106L (no) Fremgangsmaate ved fremstilling av cytidin-derivater.
FI971609L (fi) Menetelmä 4a,5,9,10,11,12-heksahydro-6H-bentsofuro-(3a,3,2-ef)(2)-bentsatsepiinijohdannaisten valmistamiseksi
NO913780D0 (no) Forbedret fremgangsmaate for fremstilling av masse.
FI891338A0 (fi) Parannus menetelmään 2',3'-dideoksi-2',3'-didehydronukleosidien valmistamiseksi
FI903752A7 (fi) Menetelmä 1,2,3,4-tetrahydro-9-akridiiniamiinin johdannaisten valmistamiseksi
HU900784D0 (en) Process for preparation of new, substituted acetamide-derivatives
NO175776C (no) 1-aminopropandiol-2,3 med höy renhet, samt fremgangsmåte for fremstilling av forbindelsen
NO176098C (no) Analogifremgangsmåte for fremstilling av 2-substituerte N,N'-ditrimetoksybenzoyl-piperaziner
NO901637L (no) Fremgangsmaate ved fremstilling av antiparasittiske formuleringer.
FR2695645B1 (fr) Procédé de préparation de polyaminoborazines.
FI933755A7 (fi) Menetelmä trans-piperidiini-2,5-dikarboksylaattien valmistamiseksi
NO179101C (no) Fremgangsmåte for fremstilling av dibeskyttet 2,3-hydroksymetyl-cyklobutanol
ITTO910353A1 (it) Composti triciclici, procedimento per la loro preparazione
FI910159A7 (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten 9a-hydroksi-3-okso- 4,24(25)-stigmastadieeni-26-happojohdannaisten valmistamiseksi
NO179790C (no) Fremgangsmåte ved fremstilling av 2,3,5,6-tetraklorpyridin
DK0377437T3 (da) Fremgangsmåde til fremstilling af 2,4-diamino-6-piperidinylpyrimidin-3-N-oxid
FI930237A7 (fi) Menetelmä 4,6-dialkoksipyrimidiinien valmistamiseksi
NO174393C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 6-metyl-19-nor-pregna-4,6-diener som er 17 eventuelt 21-alkylert
AU8705491A (en) Process for the preparation of trioxane
AU6095090A (en) Process for the manufacture of parenteral application formulations
FI102166B1 (fi) Menetelmä N,N-dimetyyliaminometyyliaryyliyhdisteiden valmistamiseksi
DK0403889T3 (da) Fremgangsmåde til fremstilling af 4-amino-1,2,4-tridazol-5-oner

Legal Events

Date Code Title Description
MK1K Patent expired